Fundamental Analysis of EQONEX LTD(NASDAQ:EQOS) stock

Fundamental Rating

Taking everything into account, EQOS scores 2 out of 10 in our fundamental rating. EQOS was compared to 210 industry peers in the Capital Markets industry. EQOS may be in some trouble as it scores bad on both profitability and health. EQOS is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

EQOS had negative earnings in the past year.

In the past year EQOS has reported a negative cash flow from operations.

1.2 Ratios

EQOS's Return On Assets of -122.39% is on the low side compared to the rest of the industry. EQOS is outperformed by 98.06% of its industry peers.

		Industry Rank	Sector Rank
ROA	-122.39%
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

EQOS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for EQOS has been increased compared to 1 year ago.

EQOS has a worse debt/assets ratio than last year.

2.2 Solvency

EQOS has an Altman-Z score of -11.66. This is a bad value and indicates that EQOS is not financially healthy and even has some risk of bankruptcy.

With a decent Altman-Z score value of -11.66, EQOS is doing good in the industry, outperforming 76.21% of the companies in the same industry.

A Debt/Equity ratio of 1.65 is on the high side and indicates that EQOS has dependencies on debt financing.

EQOS has a Debt to Equity ratio of 1.65. This is amonst the worse of the industry: EQOS underperforms 82.04% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.65
Debt/FCF	N/A
Altman-Z	-11.66

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 1.08 indicates that EQOS should not have too much problems paying its short term obligations.

EQOS's Current ratio of 1.08 is amongst the best of the industry. EQOS outperforms 80.58% of its industry peers.

EQOS has a Quick Ratio of 1.08. This is a normal value and indicates that EQOS is financially healthy and should not expect problems in meeting its short term obligations.

EQOS has a better Quick ratio (1.08) than 81.55% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.08
Quick Ratio	1.08

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for EQOS have decreased strongly by -1533.22% in the last year.

Looking at the last year, EQOS shows a very strong growth in Revenue. The Revenue has grown by 1741.83%.

Measured over the past years, EQOS shows a very strong growth in Revenue. The Revenue has been growing by 77.30% on average per year.

EPS 1Y (TTM)-1533.22%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-3194.97%

Revenue 1Y (TTM)1741.83%

Revenue growth 3Y77.3%

Revenue growth 5YN/A

Revenue growth Q2QN/A

3.2 Future

EQOS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.42% yearly.

EQOS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 52.26% yearly.

EPS Next Y63.76%

EPS Next 2Y41.05%

EPS Next 3Y25.6%

EPS Next 5Y18.42%

Revenue Next Year-41.3%

Revenue Next 2Y31.89%

Revenue Next 3Y44.66%

Revenue Next 5Y52.26%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EQOS. In the last year negative earnings were reported.

Also next year EQOS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as EQOS's earnings are expected to grow with 25.60% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y41.05%

EPS Next 3Y25.6%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for EQOS!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EQONEX LTD

NASDAQ:EQOS (11/29/2022, 7:00:01 PM)

After market: 0.0869 -0.01 (-6.66%)

0.0931

-0.05 (-33.88%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap4.31M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-122.39%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.09

Health

		Industry Rank	Sector Rank
Debt/Equity	1.65
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	1.08
Quick Ratio	1.08
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-1533.22%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y63.76%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)1741.83%

Revenue growth 3Y77.3%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

EQONEX LTD (EQOS)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens